/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Alane Izu

University of the Witwatersrand(ZA)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

109

Papers

9.5K

Citations

28

h-index

55

i10-index

Alane Izu is an academic researcher from University of the Witwatersrand. The author has contributed to research in topics: Pneumonia and Respiratory Infections & SARS-CoV-2 and COVID-19 Research & Neonatal and Maternal Infections. The author has an h-index of 28, co-authored 93 publications.

ORCID: 0000-0002-5547-7223

Research Topics

Pneumonia and Respiratory Infections SARS-CoV-2 and COVID-19 Research Neonatal and Maternal Infections Streptococcal Infections and Treatments Respiratory viral infections research

Papers by this author

works

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

2021 · The Lancet · 1,200 citations

https://doi.org/10.1016/s0140-6736(21)00432-3

Merryn Voysey Sue Ann Costa Clemens Shabir A. Madhi Lily Yin Weckx

Causes of stillbirths among women from South Africa: a prospective, observational study

2019 · The Lancet Global Health · 57 citations

https://doi.org/10.1016/s2214-109x(18)30541-2

Shabir A. Madhi Carmen Briner Salome Maswime Simpiwe Mose

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19

2023 · Nature Immunology · 31 citations

https://doi.org/10.1038/s41590-023-01513-1

Paulina Kapłonek Deniz Cizmeci Gaurav Kwatra Alane Izu

Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial

2020 · The Lancet Infectious Diseases · 28 citations

https://doi.org/10.1016/s1473-3099(20)30289-9

Shabir A. Madhi Eleonora A.M.L. Mutsaerts Alane Izu W. L. Boyce

Association of infant Rib and Alp1 surface protein N-terminal domain immunoglobulin G and invasive Group B Streptococcal disease in young infants

2023 · Vaccine · 17 citations

https://doi.org/10.1016/j.vaccine.2023.01.071

Ziyaad Dangor Gaurav Kwatra A Pawłowski Per B. Fisher

Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomised trial

2023 · The Lancet Child & Adolescent Health · 13 citations

https://doi.org/10.1016/s2352-4642(23)00025-1

Courtney P. Olwagen Alane Izu Eleonora A.M.L. Mutsaerts Lisa Jose

Research topics

topics

Pneumonia and Respiratory Infections

SARS-CoV-2 and COVID-19 Research

Neonatal and Maternal Infections

Streptococcal Infections and Treatments

Respiratory viral infections research

Chat about Author

Papers

Chat

Click to start Chat